Zdrowie i gospodarka · 27/02/2023
FDA Drafts Guidance for Industry on Treating Neovascular Age-Related Macular Degeneration with New Drugs
The FDA is releasing a draft guidance for pharmaceutical companies to develop effective treatments for neovascular age-related macular degeneration, outlining eligibility criteria, trial design, and efficacy endpoints to improve clinical trial data quality.